HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Alternate models may address ‘need to better tailor survivorship care’ Jennifer Byrne
-
- As proton beam therapy use for cancer increased, ‘so did the racial disparity in receipt’ Jennifer R. Southall
- Adolescent, young adult leukemia survivors have worse long-term survival outcomes than general population Jennifer R. Southall
- Cancer Disparities Progress Report highlights ‘grim reality,’ strides toward equity Jennifer Byrne
- Deep learning-based evaluation of prostate lesions useful during active surveillance Jennifer R. Southall
- Dostarlimab shows efficacy as curative-intent treatment in rectal cancer subset Jennifer R. Southall
- Gene linked to survival after anthracyclines, anti-HER2 therapies for breast cancer Jennifer R. Southall
- Healio announces first Disruptive Innovators in Hem/Onc
- Innovation can address ‘profound inequality’ in cancer care, ASCO keynote speaker says Devin McLaughlin
-
- Medicaid expansion linked to survival gain, reduced disparities among patients with cancer Devin McLaughlin
- Neuropsychologist aims to grow diversity in her field, help cancer survivors ‘live better’ Jennifer R. Southall
- Racial disparities in cancer survival shrink with increased public welfare spending Devin McLaughlin
- Targeted therapy provides ‘phenomenal’ benefit for certain children with glioma Mark Leiser
- Trastuzumab deruxtecan extends survival in HER2-low metastatic breast cancer Jennifer R. Southall
- Combination fails to extend OS in urothelial carcinoma
- NuCana halts phase 3 study of acelarin for biliary tract cancer